MET vs TRAW · P/E 13, $52.16B cap vs rev $2.8M
MetLife Inc (MET) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
MET does not have a complete income-statement cache yet.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
MET currently screens at market cap $52.16B and trailing P/E 12.7. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the MET and TRAW stock pages for the full models.
Not investment advice.